PYGO2 is overexpressed in multiple myeloma patients with 1q21 amplification, driving plasma cell proliferation and cell cycle progression
Rattachement africain : it, us. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Abstract Chromosome 1q21 copy number alterations (1q21+) are among the most frequent secondary events in multiple myeloma (MM), correlating with poor prognosis and therapy resistance. However, the molecular drivers of this lesion remain poorly defined. Here, we identify PYGO2, a Wnt/β-catenin co-activator located on 1q21, as a critical effector of MM progression. Analysis of primary CD138 + plasma cells and public datasets revealed that PYGO2 expression is significantly increased in 1q21+ patients and correlates with chromosome 1q copy number. High PYGO2 levels were associated with adverse cytogenetics and shorter progression-free and overall survival. Functional studies showed that PYGO2 knockdown (KD) in 1q21+ cell lines impaired proliferation, induced cell cycle perturbation coupled with CCND1 downregulation and reduced H3K4me3 enrichment, while increasing Carfilzomib and Bortezomib sensitivity. Conversely, PYGO2 overexpression enhanced cell growth and proteasome inhibitor resistance. RNA-seq profiling of KD cells revealed coordinated suppression of canonical Wnt/TCF target genes involved in proliferation and reshaped the replication stress and DNA damage response transcriptome, suggesting enhanced replication stress. RNA-seq profiling of KD cells also revealed suppression of oncogenic and immunomodulatory pathways, suggesting a broader role in tumor-microenvironment crosstalk. Overall, our data establish PYGO2 as a previously unrecognized effector of 1q21-driven aggressiveness in MM and suggest that it represents a therapeutic vulnerability in high-risk 1q21+ MM patients.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- PYGO2 is overexpressed in multiple myeloma patients with 1q21 amplification, driving plasma cell proliferation and cell cycle progression
- Date Crossref
- 11/07/2026
- Éditeur
- Springer Science and Business Media LLC
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
University of Parma Department of Medicine and Surgery pays non établi dans la noticeUniversité ou école supérieure
-
Ospedale di Parma pays non établi dans la noticeÉtablissement de santé
-
Tumori Foundation pays non établi dans la noticeOrganisation à but non lucratif
-
Fondazione IRCCS Istituto Nazionale dei Tumori pays non établi dans la noticeÉtablissement de santé
-
Hematology and BMT Unit pays non établi dans la noticeInstitution
-
"Istituto Nazionale dei Tumori" Foundation pays non établi dans la noticeOrganisation à but non lucratif
Department of Medicine and Surgery — University of Parma, Ospedale di Parma et Tumori Foundation, avec 3 autres affiliations.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.